Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

By Tsukuda Mamoru   Mikami Yasukazu   Tanigaki Yuji   Katori Hideaki   Horiuchi Choichi   Ikeda Yoichi   Taguchi Takahide   Ono Machiko   Yoshida Takahumi   Sakuma Yasunori   Aikoh Ken  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite

Nab‐paclitaxel‐based compared to docetaxel‐based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 481-489

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

By Zhang Jingsong   Lee Julia   Urba Susan   Foster Jared   Worden Francis  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 910-916

Informa Healthcare

Access to resources Recommend Favorite

Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation

By Ko Eric C.   Genden Eric M.   Misiukiewicz Krzysztof   Som Peter M.   Kostakoglu Lale   Chen Chien-Ting   Packer Stuart   Kao Johnny  

Oncology Reports, Vol. 27, Iss. 2, 2012-02 ,pp. : 467-474

Spandidos Publications

Access to resources Recommend Favorite

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer - A randomised phase II EORTC trial

By Bartelink H.   Van den Bogaert W.   Horiot J.-C.   Jager J.   van Glabbeke M.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 667-673

Elsevier

Access to resources Recommend Favorite